The company was founded in March 2000. Since its launch in 2010, it has been adhering to the “product leading” strategy, and has enriched the company's product line through various methods such as epitaxial mergers and acquisitions, cooperative agents, independent research and development, and overseas introduction, etc., and has expanded from the narrow and single orthopedic treatment field at the beginning of the market to the existing cardiovascular and cerebrovascular treatment fields. A new pattern of multi-product-driven performance growth has gradually emerged. The company is mainly engaged in R&D, production and sales of pharmaceuticals. The company's main products include amlodipine tablets, injectable creatine phosphate, ginkgo damole injections, olmesartan amlodipine tablets, edoxaban toluene sulfonate tablets, pravastatin tablets, deer guanadine injections, sodium hyaluronate injections, multivitamin injections, potassium chloride sustained-release tablets, injectable potassium magnesium aspartate, sitagliptin metformin extended-release tablets, flurbiprofen injections, merogabarine benzenesulfonate tablets, deoxynucleic acid Sodium injection (DNA), levocarnitine injection, compound ammonium glycyrrhizinate S for injection, cephalexide sodium for injection, compound head Faclor capsules, injectable calcium levofolate, fluorouracil for injection, cyclophosphamide for injection, and Pingyangmycin hydrochloride for injection. Corporate honors: In October 2018, Yuheng Pharmaceutical won the title of 2018 China's Top 100 Industrial Enterprises with Comprehensive Strength in the Chemical and Pharmaceutical Industry. In July 2018, Yuheng Pharmaceutical was listed as one of the “Top 100 Pharmaceutical Industries in China”. In June 2018, Yuheng Pharmaceutical won two awards: “2017 China's Top 100 Pharmaceutical Industry” and “2017 China Pharmaceutical Law-abiding and Honest Enterprise”. In May 2018, Yuheng Pharmaceutical won the 2018 Brand Value Assessment Enterprise Brand List, “2022 Top 100 Chinese Chemical Companies”, “Specialized and New” SMEs, “2022 Outstanding Private Enterprises in Datong City”, “2022 Outstanding Tax Contribution Award”, “Outstanding Economic Contribution Enterprise Award”, and “Outstanding Tax Contribution Enterprise Award”.